Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun;35(6):509-539.
doi: 10.14670/HH-18-199. Epub 2020 Jan 10.

How galectins have become multifunctional proteins

Affiliations
Review

How galectins have become multifunctional proteins

Gabriel García Caballero et al. Histol Histopathol. 2020 Jun.

Abstract

Having identified glycans of cellular glycoconjugates as versatile molecular messages, their recognition by sugar receptors (lectins) is a fundamental mechanism within the flow of biological information. This type of molecular interplay is increasingly revealed to be involved in a wide range of (patho)physiological processes. To do so, it is a vital prerequisite that a lectin (and its expression) can develop more than a single skill, that is the general ability to bind glycans. By studying the example of vertebrate galectins as a model, a total of five relevant characteristics is disclosed: i) access to intra- and extracellular sites, ii) fine-tuned gene regulation (with evidence for co-regulation of counterreceptors) including the existence of variants due to alternative splicing or single nucleotide polymorphisms, iii) specificity to distinct glycans from the glycome with different molecular meaning, iv) binding capacity also to peptide motifs at different sites on the protein and v) diversity of modular architecture. They combine to endow these lectins with the capacity to serve as multi-purpose tools. Underscoring the arising broad-scale significance of tissue lectins, their numbers in terms of known families and group members have steadily grown by respective research that therefore unveiled a well-stocked toolbox. The generation of a network of (ga)lectins by evolutionary diversification affords the opportunity for additive/synergistic or antagonistic interplay in situ, an emerging aspect of (ga)lectin functionality. It warrants close scrutiny. The realization of the enormous potential of combinatorial permutations using the five listed features gives further efforts to understand the rules of functional glycomics/lectinomics a clear direction.

PubMed Disclaimer

References

    1. Ackerman S.J., Corrette S.E., Rosenberg H.F., Bennett J.C., Mastrianni D.M., Nichelson-Weller A., Weller P.F., Chin D.T. and Tenen D.G. (1993). Molecular cloning and characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase). J. Immunol. 150, 456-468. - PubMed
    1. Ahmad N., Gabius H.-J., André S., Kaltner H., Sabesan S., Roy R., Liu B., Macaluso F. and Brewer C.F. (2004). Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes. J. Biol. Chem. 279, 10841- 10847. - PubMed
    1. Akahani S., Nangia-Makker P., Inohara H., Kim H.-R.C. and Raz A. (1997). Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. Cancer Res. 57, 5272-5276. - PubMed
    1. Amano M., Eriksson H., Manning J.C., Detjen K.M., André S., Nishimura S.-I., Lehtiö J. and Gabius H.-J. (2012). Tumour suppressor p16INK4a: anoikis-favouring decrease in N/O-glycan/cell surface sialylation by down-regulation of enzymes in sialic acid biosynthesis in tandem in a pancreatic carcinoma model. FEBS J. 279, 4062- 4080. - PubMed
    1. André S., Kojima S., Yamazaki N., Fink C., Kaltner H., Kayser K. and Gabius H.-J. (1999). Galectins-1 and -3 and their ligands in tumor biology. Non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and in their expression by breast and colorectal carcinomas with/without metastatic propensity. J. Cancer Res. Clin. Oncol. 125, 461-474. - PubMed

Grants and funding

LinkOut - more resources